Characterization of multiple immune defects in human malignant lymphoma

Area of Science:

• Immunology
• Oncology
• Hematology

Background:

• Impaired lymphocyte reactivity is a hallmark of certain hematologic malignancies.
• Understanding these immune dysfunctions is crucial for developing effective cancer therapies.

Purpose of the Study:

• To investigate the mechanisms underlying impaired in vitro lymphocyte responses to concanavalin A in patients with Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL).
• To differentiate between mechanisms in untreated and successfully treated patients.

Main Methods:

• Analysis of in vitro lymphocyte responsiveness to concanavalin A in 63 patients with HD or NHL.
• Preculturing of lymphocytes to assess enhanced responsiveness.
• Detection and quantification of suppressor cell activity.

Main Results:

• Most untreated patients showed partially restored lymphocyte responses after preculturing, but not full normalization.
• Suppressor cells were present in a subset of patients, with varying correlation to clinical features in NHL but not HD.
• Successfully treated patients exhibited either normal or profoundly impaired, irreversible lymphocyte responses.

Conclusions:

• Multiple, coexisting mechanisms contribute to impaired lymphocyte reactivity in untreated HD and NHL.
• A single, irreversible mechanism explains immune impairment in successfully treated patients, suggesting distinct disease phases.